Drugmakers Saw Robust ROI and Lower Development Costs in 2021, Says Analysis Post author:PacConAdmin Post published:January 12, 2022 Post category:Drug Industry Daily It’s been a banner year for the financial side of the pharmaceutical industry. Source: Drug Industry Daily You Might Also Like User Fees in the Balance July 29, 2022 FDA Expert Panel Shoots Down Chronic Kidney Disease Drug December 8, 2021 CDC Panel Recommends Booster Doses in Children Age Five to 11 May 19, 2022